Q1 2025 · 13F-HR
Opaleye Management Inc.holdings as filed
Filed 2025-05-15 · accession 0001641172-25-010914
$449.2M
Reported value
45
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 415858109 | HROW | HARROW HEALTH INC | $105.2M | 23.4% | 3,955,000 | Common | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $37.0M | 8.24% | 2,852,070 | Common | SOLE |
| 80303D305 | SNWV | SANUWAVE HEALTH INC | $34.4M | 7.65% | 972,002 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $33.3M | 7.42% | 2,260,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $26.0M | 5.78% | 490,000 | Common | SOLE |
| 192005106 | CDXS | CODEXIS INC | $25.6M | 5.69% | 9,500,000 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $23.9M | 5.32% | 3,550,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $21.1M | 4.70% | 535,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $13.9M | 3.09% | 1,975,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $11.7M | 2.60% | 1,595,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $8.7M | 1.93% | 395,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $7.4M | 1.64% | 1,730,000 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS | $6.8M | 1.52% | 1,195,000 | Common | SOLE |
| 38341PAA0 | GOSS 5 06/01/27 | GOSSAMER BIO INC | $6.3M | 1.41% | 11,500,000 | Common | SOLE |
| 035255108 | ANIK | ANIKA THERAPEUTICS INC | $5.9M | 1.32% | 395,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.1M | 1.13% | 105,000 | Common | SOLE |
| 98419J206 | XOMA | XOMA CORP DEL | $5.0M | 1.12% | 253,043 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $5.0M | 1.11% | 795,000 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC | $4.8M | 1.07% | 172,357 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $4.7M | 1.05% | 4,287,415 | Common | SOLE |
| 032724106 | ANAB | ANAPTYS BIO INC | $4.7M | 1.04% | 250,933 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $4.6M | 1.01% | 6,000,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.2M | 0.94% | 85,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $4.1M | 0.92% | 1,914,077 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $4.0M | 0.89% | 163,988 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $4.0M | 0.89% | 1,615,000 | Common | SOLE |
| 05380C102 | RCEL | AVITA MEDICAL INC | $3.6M | 0.80% | 440,000 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $3.5M | 0.78% | 2,209,998 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $3.2M | 0.70% | 1,985,000 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $2.7M | 0.60% | 666,503 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $2.1M | 0.46% | 175,000 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $2.0M | 0.45% | 3,225,000 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.0M | 0.44% | 300,000 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $1.8M | 0.41% | 250,000 | Common | SOLE |
| 68404V209 | OPTNUSD | OPTINOSE INC | $1.8M | 0.39% | 193,039 | Common | SOLE |
| 67577R102 | IRD | OPUS GENETICS INC | $1.5M | 0.34% | 1,175,000 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $1.5M | 0.34% | 375,000 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $1.4M | 0.31% | 62,501 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $1.4M | 0.30% | 115,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $1.3M | 0.30% | 465,000 | Common | SOLE |
| 800677106 | SGMO | SANGAMO THERAPEUTICS INC | $691,869 | 0.15% | 1,055,000 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $590,100 | 0.13% | 420,000 | Common | SOLE |
| 48115J109 | DERM | JOURNEY MEDICAL CORP | $409,006 | 0.09% | 69,323 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $218,500 | 0.05% | 190,000 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $92,106 | 0.02% | 110,571 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.